Use of Antiretroviral Drugs to Prevent HIV-1 Transmission Through Breast-feeding: From Animal Studies to Randomized Clinical Trials
- 1 February 2004
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 35 (2) , 178-187
- https://doi.org/10.1097/00126334-200402010-00013
Abstract
The major remaining challenge in the prevention of mother-to-child transmission is the reduction of the risk in settings where breast-feeding is common. This review gives an update on ongoing or planned antiretroviral intervention studies in resource-limited settings that are aimed at reducing the risk of mother-to-infant HIV transmission during lactation. These strategies include antiretroviral therapy given to the mother to reduce viral load in plasma and breast milk as well as antiretroviral regimens providing prophylaxis to uninfected infants during the period of breast-feeding. The rationale for the interventions based on animal models and human studies is described as well as the study designs of clinical trials. Potential risks and benefits of these interventions to mothers and infants are also highlighted. Laboratory studies nested within several of these trials will provide a better understanding of the pathogenesis of postnatal HIV transmission and its potential prevention using antiretroviral drugs.Keywords
This publication has 31 references indexed in Scilit:
- Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV TransmissionA Randomized TrialJAMA, 2002
- Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trialThe Lancet, 2002
- Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West AfricaAIDS, 2002
- Two Low Doses of Tenofovir Protect Newborn Macaques against Oral Simian Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2001
- Prevention of Mother-to-Child HIV Transmission in Resource-Poor CountriesJAMA, 2000
- Prophylactic and Therapeutic Benefits of Short-Term 9-[2-( R )-(Phosphonomethoxy)Propyl]Adenine (PMPA) Administration to Newborn Macaques following Oral Inoculation with Simian Immunodeficiency Virus with Reduced Susceptibility to PMPAJournal of Virology, 2000
- Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infectionAIDS, 1998
- Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDSAntimicrobial Agents and Chemotherapy, 1995
- Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infectionAntimicrobial Agents and Chemotherapy, 1992